Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06353399 · ClinicalTrials.gov registry record · NA
Guided Bone Regeneration With and Without the Use of Intra-marrow Penetrations
A NA study of Ridge Augmentation, sponsored by University of Louisville.
- Recruiting
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 2
- Study locations
NCT06353399: Recruiting NA study of Ridge Augmentation, sponsored by University of Louisville.
NCT06353399 is a NA study of Ridge Augmentation that is actively recruiting participants, run by University of Louisville. The registered enrollment target is 24 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06353399, a NA study of Ridge Augmentation, is actively recruiting participants, sponsored by University of Louisville.
- RECRUITING
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 2
- Study locations
Study Summary
The primary aims of this study are to compare, after 6 months, the clinical and histologic results of intra-marrow penetrations vs no intra-marrow penetrations when performing guided bone regeneration procedures.
Conditions Studied
Interventions
- PROCEDURE Intra-marrow penetrations
- PROCEDURE No Intra-marrow penetrations
Study Locations (2)
Kentucky
- University of Louisville - Louisville
- University of Louisville - Louisville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2023-06-15 |
| Est. Completion | 2024-12-31 |
| Phase | NA |
What NCT06353399 shows while recruiting
NCT06353399 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Ridge Augmentation appearing as the primary indexed condition, and to 2 interventions - of which Intra-marrow penetrations is the first listed.
NCT06353399 reports a single indexed study location in Kentucky.
Frequently Asked Questions
What is clinical trial NCT06353399 about?
NCT06353399 is a clinical study titled "Guided Bone Regeneration With and Without the Use of Intra-marrow Penetrations". The primary aims of this study are to compare, after 6 months, the clinical and histologic results of intra-marrow penetrations vs no intra-marrow penetrations when performing guided bone regeneration procedures.
What is the current status of trial NCT06353399?
This trial is currently recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2023-06-15. Estimated completion is 2024-12-31.
What conditions does trial NCT06353399 study?
This clinical trial studies the following conditions: Ridge Augmentation.
What interventions are being tested in trial NCT06353399?
The interventions under investigation include: Intra-marrow penetrations (PROCEDURE), No Intra-marrow penetrations (PROCEDURE).
Who is sponsoring clinical trial NCT06353399?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06353399 being conducted?
This trial has 2 study locations across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ridge Augmentation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06353399's enrollment target sits among peer trials
24 1736th of 2000 higher than 246 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI